We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FREE
2626
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $316K | ﹤0.01% |
44,144
+2,153
| +5% | +$19.3K |
|
|
EIGR
2627
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $316K | ﹤0.01% |
1,271
-26
| -2% | -$4.11K |
|
|
CBAY
2628
DELISTED
Cymabay Therapeutics
CBAY
| $316K | ﹤0.01% |
101,595
-4,107
| -4% | -$12.9K |
|
2629
Commercial Vehicle Group
CVGI
$147M
| $314K | ﹤0.01% |
37,176
+2,616
| +8% | +$21.2K |
|
|
VBIV
2630
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $314K | ﹤0.01% |
6,312
-39
| -0.6% | -$1.93K |
|
2631
EverQuote
EVER
$906M
| $313K | ﹤0.01% |
19,355
+906
| +5% | +$13.7K |
|
2632
ALX Oncology
ALXO
$290M
| $311K | ﹤0.01% |
18,373
+1,054
| +6% | +$18K |
|
2633
FS Bancorp
FSBW
$320M
| $311K | ﹤0.01% |
10,048
-1,620
| -14% | -$52.7K |
|
|
FXLV
2634
DELISTED
F45 Training Holdings Inc.
FXLV
| $311K | ﹤0.01% |
29,106
+15,105
| +108% | +$195K |
|
2635
Five Star Bancorp
FSBC
$1.13B
| $310K | ﹤0.01% |
10,946
+63
| +0.6% | +$1.9K |
|
|
FRBK
2636
DELISTED
Republic First Bancorp Inc
FRBK
| $310K | ﹤0.01% |
59,991
-7,055
| -11% | -$33.9K |
|
2637
Arbutus Biopharma
ABUS
$915M
| $309K | ﹤0.01% |
103,778
+13,243
| +15% | +$40.5K |
|
|
RPT
2638
Rithm Property Trust
RPT
$93.7M
| $309K | ﹤0.01% |
4,396
-433
| -9% | -$31.5K |
|
2639
Amalgamated Financial
AMAL
$1.49B
| $308K | ﹤0.01% |
17,119
-1,530
| -8% | -$26.1K |
|
2640
Altimmune
ALT
$599M
| $306K | ﹤0.01% |
50,234
+2,094
| +4% | +$15.4K |
|
2641
Cogent Biosciences
COGT
$7.24B
| $306K | ﹤0.01% |
40,912
+2,057
| +5% | +$14.3K |
|
|
LBC
2642
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $304K | ﹤0.01% |
22,842
-1,481
| -6% | -$19.8K |
|
2643
Matrix Service
MTRX
$335M
| $301K | ﹤0.01% |
36,650
-3,041
| -8% | -$23K |
|
2644
Hooker Furnishings Corp
HOFT
$166M
| $300K | ﹤0.01% |
15,825
-1,248
| -7% | -$26.6K |
|
2645
HF Foods Group
HFFG
$83.4M
| $299K | ﹤0.01% |
44,905
-3,349
| -7% | -$23.2K |
|
2646
First Bank
FRBA
$454M
| $296K | ﹤0.01% |
20,813
-1,942
| -9% | -$27.9K |
|
|
AFCG
2647
AFC Gamma
AFCG
$63.4M
| $295K | ﹤0.01% |
22,532
+6,750
| +43% | +$91.2K |
|
2648
Full House Resorts
FLL
$89M
| $295K | ﹤0.01% |
30,680
+9,657
| +46% | +$89.6K |
|
2649
Oramed Pharmaceuticals
ORMP
$179M
| $294K | ﹤0.01% |
34,046
+9,611
| +39% | +$98.5K |
|
|
JNCE
2650
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $292K | ﹤0.01% |
43,035
-1,683
| -4% | -$12K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.